Skip to content

Iván Mindlin

Paris Brain Institute, ICM, Inserm, CNRS, Sorbonne Université, Paris, France.

3 papers in the library · 8 citations · publishing 2024-2025

Papers

Nonequilibrium brain dynamics elicited as the origin of perturbative complexity.

PLoS computational biology June 6, 2025 Wiep Stikvoort, Eider Pérez-Ordoyo, Iván Mindlin et al. 3 citations

A person's level of consciousness can be assessed by how the brain reacts to stimulation, but this study shows that the brain's unperturbed activity already contains that information. Using personalized whole-brain models fitted to resting-state fMRI data from people in altered states of consciousness (deep sleep, disorders of consciousness), the researchers measured the brain's out-of-equilibrium dynamics—specifically, the asymmetry of effective connections and time irreversibility. They found that states with lower arousal or awareness had less asymmetric connectivity, less irreversibility, and lower complexity in simulated responses compared to controls. The asymmetry in connections drives the nonequilibrium state and, in turn, the differences in complexity.

A virtual clinical trial of psychedelics to treat patients with disorders of consciousness

bioRxiv (Cold Spring Harbor Laboratory) August 19, 2024 Naji Alnagger, Paolo Cardone, Charlotte Martial et al. 3 citations preprint

Disorders of consciousness, such as unresponsive wakefulness syndrome (UWS) and minimally conscious state (MCS), have few treatments. Using whole-brain computational models built from individual patients' fMRI and diffusion-weighted imaging data, this virtual clinical trial simulated the effects of LSD and psilocybin. The psychedelics shifted the brains of patients with disorders of consciousness closer to a critical dynamical state, with a larger effect in MCS patients. In UWS patients, the treatment response depended on structural connectivity, whereas in MCS patients it aligned with baseline functional connectivity. These results provide a computational foundation for considering psychedelics in treating disorders of consciousness and highlight the role of computational modeling in drug discovery and personalized medicine.

A Virtual Clinical Trial of Psychedelics to Treat Patients With Disorders of Consciousness

Advanced Science November 20, 2025 Paolo Cardone, Charlotte Martial, Yonatan Sanz Perl et al. 2 citations

Simulated administration of LSD and psilocybin in computational models of patients with disorders of consciousness (DoC), including unresponsive wakefulness syndrome (UWS) and minimally conscious state (MCS), shifted brain activity closer to criticality—the phase transition between order and chaos. The effect was greater in MCS patients. In UWS patients, the treatment response correlated with structural connectivity, while in MCS patients it aligned with baseline functional connectivity. These results provide a computational foundation for using psychedelics in DoC treatment and highlight the potential role of computational modeling in drug discovery and personalized medicine.